ID

17870

Description

Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00323557

Lien

https://clinicaltrials.gov/show/NCT00323557

Mots-clés

  1. 06/10/2016 06/10/2016 -
Téléchargé le

6 octobre 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Leukemia NCT00323557

Eligibility Leukemia NCT00323557

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00323557
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1) patients in complete / partial remission or those with active chronic lymphocytic leukemia (cll) with rai stage 0 to 4.
Description

In complete remission | partial response | Chronic Lymphocytic Leukemia | Rai Staging System

Type de données

boolean

Alias
UMLS CUI [1]
C0677874
UMLS CUI [2]
C1521726
UMLS CUI [3]
C0023434
UMLS CUI [4]
C1514715
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patients will not be entered while neutropenic (pmns < 500 cells/mm3) or having received rituximab within 6 months.
Description

Neutropenia | Polymorphonuclear leukocyte count | rituximab

Type de données

boolean

Alias
UMLS CUI [1]
C0027947
UMLS CUI [2]
C1271714
UMLS CUI [3]
C0393022
2. patients will not be entered while febrile (temperature > 38 degrees c) within 1 week.
Description

Fever | Body temperature measurement degrees Celsius

Type de données

boolean

Alias
UMLS CUI [1]
C0015967
UMLS CUI [2,1]
C0886414
UMLS CUI [2,2]
C0439237
3. active infection.
Description

Communicable Disease

Type de données

boolean

Alias
UMLS CUI [1]
C0009450
4. patients with known human immunodeficiency virus (hiv) infection.
Description

HIV Infection

Type de données

boolean

Alias
UMLS CUI [1]
C0019693
5. known history of allergy to granulocyte/ macrophage colony stimulating factor (gm-csf) or pneumococcal vaccine.
Description

Hypersensitivity Granulocyte-Macrophage Colony-Stimulating Factor | Hypersensitivity Pneumococcal vaccine

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0079460
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0358314
6. chemotherapy other than campath, fludarabine, cyclophosphamide, in 4 weeks.
Description

Chemotherapy | Campath | fludarabine | Cyclophosphamide

Type de données

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0939276
UMLS CUI [3]
C0059985
UMLS CUI [4]
C0010583
7. patients who have previously received pneumococcal vaccine within the preceding 12 months.
Description

Pneumococcal vaccine

Type de données

boolean

Alias
UMLS CUI [1]
C0358314
8. absolute lymphocyte count less than 500 cells/mm3.
Description

Absolute lymphocyte count

Type de données

boolean

Alias
UMLS CUI [1]
C3544087

Similar models

Eligibility Leukemia NCT00323557

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00323557
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
In complete remission | partial response | Chronic Lymphocytic Leukemia | Rai Staging System
Item
1) patients in complete / partial remission or those with active chronic lymphocytic leukemia (cll) with rai stage 0 to 4.
boolean
C0677874 (UMLS CUI [1])
C1521726 (UMLS CUI [2])
C0023434 (UMLS CUI [3])
C1514715 (UMLS CUI [4])
Item Group
C0680251 (UMLS CUI)
Neutropenia | Polymorphonuclear leukocyte count | rituximab
Item
1. patients will not be entered while neutropenic (pmns < 500 cells/mm3) or having received rituximab within 6 months.
boolean
C0027947 (UMLS CUI [1])
C1271714 (UMLS CUI [2])
C0393022 (UMLS CUI [3])
Fever | Body temperature measurement degrees Celsius
Item
2. patients will not be entered while febrile (temperature > 38 degrees c) within 1 week.
boolean
C0015967 (UMLS CUI [1])
C0886414 (UMLS CUI [2,1])
C0439237 (UMLS CUI [2,2])
Communicable Disease
Item
3. active infection.
boolean
C0009450 (UMLS CUI [1])
HIV Infection
Item
4. patients with known human immunodeficiency virus (hiv) infection.
boolean
C0019693 (UMLS CUI [1])
Hypersensitivity Granulocyte-Macrophage Colony-Stimulating Factor | Hypersensitivity Pneumococcal vaccine
Item
5. known history of allergy to granulocyte/ macrophage colony stimulating factor (gm-csf) or pneumococcal vaccine.
boolean
C0020517 (UMLS CUI [1,1])
C0079460 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0358314 (UMLS CUI [2,2])
Chemotherapy | Campath | fludarabine | Cyclophosphamide
Item
6. chemotherapy other than campath, fludarabine, cyclophosphamide, in 4 weeks.
boolean
C0392920 (UMLS CUI [1])
C0939276 (UMLS CUI [2])
C0059985 (UMLS CUI [3])
C0010583 (UMLS CUI [4])
Pneumococcal vaccine
Item
7. patients who have previously received pneumococcal vaccine within the preceding 12 months.
boolean
C0358314 (UMLS CUI [1])
Absolute lymphocyte count
Item
8. absolute lymphocyte count less than 500 cells/mm3.
boolean
C3544087 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial